US2019209632A1PendingUtilityA1

Pharmaceutical Composition for Preventing and Treating Alpha Herpes Virus Infection, Containing, As Active Ingredient, Elaeocarpus Sylvestris Extract or Fraction Thereof

41
Assignee: GENENCELL CO LTDPriority: Sep 9, 2016Filed: Apr 28, 2017Published: Jul 11, 2019
Est. expirySep 9, 2036(~10.2 yrs left)· nominal 20-yr term from priority
A61K 2236/33A61K 31/365A61K 31/235A23L 33/105A23V 2002/00A61P 31/22A61K 36/185
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating alpha-herpesvirus infection comprising an Elaeocarpus sylvestris extract or a fraction thereof as an active ingredient, and can effectively prevent, treat or alleviate an alpha-herpesvirus and diseases caused thereby, such as herpes, encephalitis, genital herpes, chicken pox, or herpes zoster.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition for preventing and treating alpha-herpesvirus infection comprising an  Elaeocarpus sylvestris  extract or a fraction thereof as an active ingredient. 
     
     
         2 . The pharmaceutical composition of  claim 1 , wherein the  Elaeocarpus sylvestris  extract is obtained by extraction with water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof. 
     
     
         3 . The pharmaceutical composition of  claim 2 , wherein the  Elaeocarpus sylvestris  extract is a 50% ethanol extract. 
     
     
         4 . The pharmaceutical composition of  claim 1 , wherein the alpha-herpesvirus is one or more viruses selected from among varicella-zoster virus (VZV), herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2). 
     
     
         5 . The pharmaceutical composition of  claim 1 , wherein the alpha-herpesvirus infection is any one or more selected from among herpes, genital herpes, chickenpox, and herpes zoster. 
     
     
         6 . The pharmaceutical composition of  claim 1 , wherein the  Elaeocarpus sylvestris  extract comprises any one or more selected from the group consisting of methyl gallate, geraniin and casuarictin. 
     
     
         7 . A pharmaceutical formulation for preventing and treating alpha-herpesvirus infection comprising an  Elaeocarpus sylvestris  extract or a fraction thereof as an active ingredient. 
     
     
         8 . A health food for preventing and alleviating alpha-herpesvirus infection comprising an  Elaeocarpus sylvestris  extract or a fraction thereof as an active ingredient. 
     
     
         9 . The health food of  claim 8 , wherein the  Elaeocarpus sylvestris  extract is obtained by extraction with water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof. 
     
     
         10 . The health food of  claim 8 , wherein the alpha-herpesvirus is one or more viruses selected from among varicella-zoster virus (VZV), herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2). 
     
     
         11 . The health food of  claim 8 , wherein the alpha-herpesvirus infection is one or more selected from among herpes, encephalitis, genital herpes, chickenpox, and herpes zoster. 
     
     
         12 . The health food of  claim 8 , wherein the  Elaeocarpus sylvestris  extract comprises any one or more selected from the group consisting of methyl gallate, geraniin and casuarictin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.